COMPARISON BETWEEN 18F-PSMA AND 18F-FDG RADIOTRACERS FOR PET/CT IN THE EVALUATION OF PATIENTS WITH METASTATIC MELANOMA

IF 1.8 Q3 HEMATOLOGY
Thiago Soare Rocha Alves, Diego Mendanha, Ellen Lima, Natália Tobar, Juliana Souza, Ligia Macedo, Allan Oliveira Santos, Mariana Cunha Lopes Lima, Elba Etchebehere, Carmen Silva Passos Lima
{"title":"COMPARISON BETWEEN 18F-PSMA AND 18F-FDG RADIOTRACERS FOR PET/CT IN THE EVALUATION OF PATIENTS WITH METASTATIC MELANOMA","authors":"Thiago Soare Rocha Alves,&nbsp;Diego Mendanha,&nbsp;Ellen Lima,&nbsp;Natália Tobar,&nbsp;Juliana Souza,&nbsp;Ligia Macedo,&nbsp;Allan Oliveira Santos,&nbsp;Mariana Cunha Lopes Lima,&nbsp;Elba Etchebehere,&nbsp;Carmen Silva Passos Lima","doi":"10.1016/j.htct.2025.103786","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction/Justification</h3><div>PET/CT has emerged in the last two decades as a dominant imaging modality used for staging, monitoring response and surveillance of melanoma using 18F-FDG as radiotracer. Recent publications have demonstrated the possibility of use of 18F-PSMA PET/CT as an additional resource to the evaluation of melanoma, due to the expression of Prostate-Specific Membrane Antigen protein (PSMA) in these cancer cells and because anti-PSMA antibodies react with malignant melanoma neo vasculature.</div></div><div><h3>Objectives</h3><div>Would 18F-PSMA PET/CT have the potential role of a novel diagnostic imaging technique in melanoma cases?</div></div><div><h3>Materials and Methods</h3><div>Eleven participants with diagnoses of metastatic melanoma underwent 18F-FDG PET/CT and 18F-PSMA PET/CT (24-hours interval), and the lesions uptakes were evaluated with both radiotracers. The results were grouped in three categories: A - greater expression of 18F-PSMA compared to 18F-FDG; B – equivalent uptake between the radiotracers; and C - greater expression of 18F-FDG compared to 18F-PSMA.</div></div><div><h3>Results</h3><div>18,1% of participants were in category A, 54,5% in category B and 27,2% in category C. The lesions with greater 18F-PSMA uptake compared to 18F-FDG were mainly in the brain, lungs, adrenals, and scattered throughout the chest. Furthermore, one subjects presented only 18F-PSMA uptake in brain metastasis, showing the importance of this method to the clinical follow-up of these patients. Our findings align with the Chang et al.’s, who demonstrated in vitro expression of PSMA in the neovasculature of melanoma lesion and with Snow et al.’s who observed PSMA positivity in endothelial cells of capillaries within stage III/IV melanoma metastases.</div></div><div><h3>Conclusion</h3><div>Therefore, apart from the use of 18F-PSMA PET/CT in staging prostate cancer patients, this method shows a great potential in the evaluating of metastatic melanoma, still needing further and longer studies to confirm these advantages.</div></div>","PeriodicalId":12958,"journal":{"name":"Hematology, Transfusion and Cell Therapy","volume":"47 ","pages":"Article 103786"},"PeriodicalIF":1.8000,"publicationDate":"2025-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hematology, Transfusion and Cell Therapy","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2531137925000549","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction/Justification

PET/CT has emerged in the last two decades as a dominant imaging modality used for staging, monitoring response and surveillance of melanoma using 18F-FDG as radiotracer. Recent publications have demonstrated the possibility of use of 18F-PSMA PET/CT as an additional resource to the evaluation of melanoma, due to the expression of Prostate-Specific Membrane Antigen protein (PSMA) in these cancer cells and because anti-PSMA antibodies react with malignant melanoma neo vasculature.

Objectives

Would 18F-PSMA PET/CT have the potential role of a novel diagnostic imaging technique in melanoma cases?

Materials and Methods

Eleven participants with diagnoses of metastatic melanoma underwent 18F-FDG PET/CT and 18F-PSMA PET/CT (24-hours interval), and the lesions uptakes were evaluated with both radiotracers. The results were grouped in three categories: A - greater expression of 18F-PSMA compared to 18F-FDG; B – equivalent uptake between the radiotracers; and C - greater expression of 18F-FDG compared to 18F-PSMA.

Results

18,1% of participants were in category A, 54,5% in category B and 27,2% in category C. The lesions with greater 18F-PSMA uptake compared to 18F-FDG were mainly in the brain, lungs, adrenals, and scattered throughout the chest. Furthermore, one subjects presented only 18F-PSMA uptake in brain metastasis, showing the importance of this method to the clinical follow-up of these patients. Our findings align with the Chang et al.’s, who demonstrated in vitro expression of PSMA in the neovasculature of melanoma lesion and with Snow et al.’s who observed PSMA positivity in endothelial cells of capillaries within stage III/IV melanoma metastases.

Conclusion

Therefore, apart from the use of 18F-PSMA PET/CT in staging prostate cancer patients, this method shows a great potential in the evaluating of metastatic melanoma, still needing further and longer studies to confirm these advantages.
18f-psma和18f-fdg示踪剂用于pet / ct评估转移性黑色素瘤患者的比较
在过去的二十年中,pet /CT作为一种主要的成像方式出现,使用18F-FDG作为放射性示踪剂,用于黑色素瘤的分期、监测反应和监测。由于前列腺特异性膜抗原蛋白(PSMA)在这些癌细胞中的表达,以及抗PSMA抗体与恶性黑色素瘤的新血管系统发生反应,最近的出版物已经证明了使用18F-PSMA PET/CT作为评估黑色素瘤的额外资源的可能性。目的:18F-PSMA PET/CT是否具有在黑色素瘤病例中作为一种新的诊断成像技术的潜在作用?材料和方法即使是诊断为转移性黑色素瘤的参与者也接受了18F-FDG PET/CT和18F-PSMA PET/CT(间隔24小时),并使用两种放射性示踪剂评估病变的吸收情况。结果分为三类:A -与18F-FDG相比,18F-PSMA的表达更高;放射性示踪剂之间的B -等效吸收;C - 18F-FDG的表达高于18F-PSMA。结果18.1%的参与者属于A类,54.5%的参与者属于B类,27.2%的参与者属于c类。与18F-FDG相比,18F-PSMA摄取更多的病变主要在脑、肺、肾上腺,并分散在整个胸部。此外,一名受试者在脑转移中仅表现出18F-PSMA摄取,表明该方法对这些患者的临床随访具有重要意义。我们的研究结果与Chang等人的研究结果一致,Chang等人在黑色素瘤病变的新生血管中证实了PSMA的体外表达,而Snow等人在III/IV期黑色素瘤转移的毛细血管内皮细胞中观察到PSMA阳性。因此,除了18F-PSMA PET/CT在前列腺癌患者分期中的应用外,该方法在评估转移性黑色素瘤方面具有很大的潜力,这些优势还需要进一步、更长的研究来证实。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.40
自引率
4.80%
发文量
1419
审稿时长
30 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信